SCHEMBL26458561

SCHEMBL26458561

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)C4(c6ccccc6Oc6ccccc64)c4c(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cccc4-5)n3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 12/20 0.38
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ADORA2B P29275 1/20 0.32
NTSR1 P30989 1/20 0.31
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458598 0.98 PDK2 (0.39) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL22216542 0.98 PDK2 (0.39) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL26458588 0.98 PDK2 (0.36) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL22216511 0.98 PDK2 (0.39) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL26458425 0.98 PDK2 (0.36) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL26458398 0.96 MEN1 (0.36) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL23642969 0.94 MEN1 (0.40) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL26458600 0.94 MEN1 (0.42) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL21151221 0.93 MEN1 (0.41) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL26458563 0.93 MEN1 (0.43) PDK2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 PDK2 2128/4885MEN1 353/4885KMT2A 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.